ClinConnect ClinConnect Logo
Search / Trial NCT04180709

CBT to Reduce Insomnia and Improve Social Recovery in Early Psychosis

Launched by UNIVERSITY OF CAMBRIDGE · Nov 25, 2019

Trial Information

Current as of June 18, 2025

Completed

Keywords

Cognition Social Recovery Immunopsychiatry Daily Function Sleep Disturbances Insomnia

ClinConnect Summary

The study will take place in three stages; an initial survey, an eight week study period and a follow-up period for an additional eight weeks.

Stage One: Perceptions of Sleep Problems and Their Treatment in Psychosis:

Clinicians and service users will receive an online link to a short 18-question survey (primarily multiple choice) that should take approximately 5 min to complete. Although they can complete this online, a paper copy can be provided if they prefer to handwrite their answers.

Stage Two: Randomised 8 Week Study:

At our initial phone or NHS approved video platform meeting pa...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Experiencing or having experienced a First Episode of Psychosis (FEP) within the past 5 years.
  • Currently participating in CPFT CAMEO EIPS or NSFT EIS and intending to continue TAU with the specified service for at least the next 4 months.
  • Mental capacity for consent.
  • Currently experiencing threshold level (score ≤ 16 on SCI-8) of disrupted sleep.
  • Adults 18 years or older.
  • Ability to understand and follow therapeutic instructions necessary for experiment and respond to online questionnaires.
  • Illness duration less than or equal to 5 years. Onset of illness was defined as first contact with psychiatric services for psychotic symptoms.
  • Access to the internet.
  • Exclusion Criteria:
  • Too unwell to viably participate in study.
  • A diagnosis of drug induced psychosis or bipolar disorder.
  • Psychotic disorder due to a medical or physical disease (i.e. considered to have an organic basis).
  • Current drug or alcohol dependency.
  • Currently taking prescribed sleep medication or intending to do so during study.
  • Currently doing night shift work.
  • Travel over 2 time zones during or within two weeks prior to assessment period.

About University Of Cambridge

The University of Cambridge, a prestigious institution renowned for its commitment to research excellence and innovation, serves as a clinical trial sponsor dedicated to advancing medical science and improving patient outcomes. Leveraging its interdisciplinary expertise and state-of-the-art facilities, the university conducts rigorous clinical trials that explore novel therapies and interventions across a wide range of health conditions. By fostering collaboration between researchers, healthcare professionals, and industry partners, the University of Cambridge aims to translate groundbreaking research into effective clinical applications, ultimately enhancing the quality of care and contributing to the global medical community.

Locations

Cambridge, Cambridgeshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Peter B Jones, PhD MD

Principal Investigator

University of Cambridge

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials